Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe

详细信息    查看全文

• 作者：Philip G. HumphreysPaul Bamborough ; Chun-wa Chung ; Peter D. Craggs ; Laurie Gordon ; Paola Grandi ; Thomas G. Hayhow ; Jameed Hussain ; Katherine L. Jones ; Matthew Lindon ; Anne-Marie Michon ; Jessica F. Renaux ; Colin J. Suckling ; David F. Tough ; Rab K. Prinjha
• 刊名：Journal of Medicinal Chemistry
• 出版年：2017
• 出版时间：January 26, 2017
• 年：2017
• 卷：60
• 期：2
• 页码：695-709
• 全文大小：905K
• ISSN：1520-4804

文摘

p300/CREB binding protein associated factor (PCAF/KAT2B) and general control nonderepressible 5 (GCN5/KAT2A) are multidomain proteins that have been implicated in retroviral infection, inflammation pathways, and cancer development. However, outside of viral replication, little is known about the dependence of these effects on the C-terminal bromodomain. Herein, we report GSK4027 as a chemical probe for the PCAF/GCN5 bromodomain, together with GSK4028 as an enantiomeric negative control. The probe was optimized from a weakly potent, nonselective pyridazinone hit to deliver high potency for the PCAF/GCN5 bromodomain, high solubility, cellular target engagement, and ≥18000-fold selectivity over the BET family, together with ≥70-fold selectivity over the wider bromodomain families.